The Scientist

» biotechnology

Most Recent

image: Thirty Years of Progress

Thirty Years of Progress

By | October 1, 2016

Since The Scientist published its first issue in October 1986, life-science research has transformed from a manual and often tedious task to a high-tech, largely automated process of unprecedented efficiency.

1 Comment

image: Smart Skin Enables Magnetoreception

Smart Skin Enables Magnetoreception

By | September 1, 2016

Researchers develop a wearable technology that can detect magnetic fields and translate the signal into a visual display—a first step toward equipping humans with an entirely new sense.

1 Comment

image: Opinion: Acquiring Extra Senses

Opinion: Acquiring Extra Senses

By | September 1, 2016

Animals’ diverse sensory abilities will guide a technology-based revolution that gives humans perception beyond our natural senses.

1 Comment

image: Exploring Alternative Codon Usage in Yeast

Exploring Alternative Codon Usage in Yeast

By | August 18, 2016

Newly discovered amino acid reassignment could have implications for certain biotech applications and RNA-based evolutionary theories.

0 Comments

image: Report: Still Lots to Learn About GE Crops

Report: Still Lots to Learn About GE Crops

By | May 17, 2016

A National Academies–led analysis evaluates the impacts of genetically engineered crops—and calls for updated regulations.

1 Comment

image: Lu on Syn Bio

Lu on Syn Bio

By | May 1, 2016

MIT researcher and Scientist to Watch Timothy Lu talks about the value of cross-disciplinary approaches in bringing synthetic biology into the clinic.

0 Comments

image: Timothy Lu: Niche Perfect

Timothy Lu: Niche Perfect

By | May 1, 2016

Associate Professor, Departments of Electrical Engineering & Computer Science and Biological Engineering, MIT. Age: 35

0 Comments

image: First Data from Anti-Aging Gene Therapy

First Data from Anti-Aging Gene Therapy

By | April 25, 2016

A biotech company reports that an experimental treatment elongated its CEO’s telomeres. 

8 Comments

image: Theranos in Criminal Probe

Theranos in Criminal Probe

By | April 19, 2016

Federal officials are investigating whether the diagnostics company misled investors.

2 Comments

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham